15.09.2014 • NewsEastmanTamincoSolutia

Eastman to Pay $2.8 Billion for Alkylamines Producer Taminco

Major US chemical producer Eastman has agreed to acquire compatriot Taminco, a major producer of alklylamines and alkylamine derivatives, for $2.8 billion. The deal proposed to be completed in the fourth quarter includes $1 billion of assumed debt.

The news agency Bloomberg said Eastman is paying 10.9 times Taminco's annual earnings before interest, taxes, depreciation and amortization, compared with an average 7.3 times EBITDA paid for chemical companies generally this year.

It would be Eastman's second biggest acquisition after its 2012 purchase of Solutia for $4.5 billion.

In a webcast to announce the acquisition, Eastman CEO Mark Costa said Taminco, headquartered at Allentown, Pennsylvania, is a strong fit with his company's strategic focus, "adding an attractive alkylamines stream to our chemical portfolio." He quantified the deal multiple as 9.5 times estimated adjusted 2014 EBITDA and eight times after expected cost savings.

The agreement includes a 30-day "go-shop" period, during which Taminco and financial adviser Morgan Stanley will solicit superior proposals. The company is permitted to enter negotiations with a bidder whose proposal is deemed superior during that period and during a 15-day period thereafter.

Eastman said the deal will strengthen its business in the food, animal nutrition, and agriculture markets, where Taminco's alklyamines technology is widely used, as well as improving the Kingsport, Tennesse-based producer's position in personal care, coatings, and oil & gas.

The transaction is expected to be accretive to earnings by 2015 and is also expected to generate around $60 million in cost savings, mostly from cost-cutting in corporate functions and operations, Eastman said.

Private equity investor Apollo acquired Taminco from another private equity firm, CVC Capital Partners, in early 2012. It floated some shares shortly afterward, before selling another tranche in 2013. The firm retains a majority stake, believed to be close to 54%. It was the only shareholder needed to vote in favor of the deal.

Taminco has production facilities in 19 countries, with an installed capacity of 1.27 million tonnes of a variety of products. According to its annual report, about 90% of sales in 2013 were derived from the agriculture, water treatment, home and personal care, animal nutrition, and oil and gas end markets. At the beginning of 2014, the company acquired Kemira's formic acid business for $191.5 million.

The Pennsylvania chemical producer believes it has number-one or number-two positions in "the vast majority" of the chemicals it makes. It reported revenues of $1.2 billion and adjusted EBITDA of $255 million for 2013, along with a net loss of $7 million.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
24.01.2025 • News

And the Winners are: Cynio, EnaDyne and Green Li-ion

The CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has given more than 100 start-ups from over 15 countries the opportunity to present their innovative ideas, products and technologies to a broad target group since its launch in 2019.